RA
AERI

Royce & Associates’s Aerie Pharmaceuticals AERI Stock Holding History

Royce & Associates’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,300
Closed -$203K – 1002
2022
Q1 		$203K Hold
22,300
– – ﹤0.01% 943
2021
Q4 		$157K Hold
22,300
– – ﹤0.01% 951
2021
Q3 		$254K Hold
22,300
– – ﹤0.01% 956
2021
Q2 		$357K Sell
22,300
-95,350
-81% -$1.64M ﹤0.01% 957
2021
Q1 		$2.1M Buy
+117,650
New +$2.03M 0.01% 749
2015
Q3 		– Sell
-86,000
Closed -$1.52M – 1233
2015
Q2 		$1.52M Hold
86,000
– – 0.01% 973
2015
Q1 		$2.69M Sell
86,000
-57,000
-40% -$1.65M 0.01% 881
2014
Q4 		$4.17M Buy
143,000
+43,000
+43% +$1.09M 0.01% 820
2014
Q3 		$2.07M Buy
+100,000
New +$1.97M 0.01% 1001

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JG
Jefferies Group New York $3.42B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return